American Journal of Infection Control

Negative outcomes associated with COVID-19 in pregnant patients make vaccination an imperative precaution for this patient population. Pregnant patients were excluded from the randomized clinical trials conducted early in the pandemic to determine

The coronavirus disease (COVID-19) is a highly contagious illness caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).1,2 Among the primary measures to reduce COVID-19 dissemination, multiple health authorities, including the

Antibiotic overuse puts patients at risk for adverse events and contributes to global antibiotic resistance. More than 2.8 million antibiotic-resistant infections occur in the United States each year, and more than 35,000 people die as a result.1

The rapid spread of the coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) has occurred at such a swift pace that it has crippled worldwide supply chains and has most critically

Since the emergence of coronavirus disease 2019 (COVID-19) in February 2020, the number of pregnant women infected with the virus and delivering by cesarean section has been steadily increasing in South Korea.1 Additionally, pregnancy is considered a

Annual influenza vaccination is recommended for all health-care personnel by the Healthcare Infection Control Practices Advisory Committee and Advisory Committee on Immunization Practices.1 Several barriers to vaccination have been previously

Surgical Site Infections (SSIs) are a significant issue that persists throughout operating suites worldwide. Despite global medical advancements, SSIs still cause substantial morbidity along with a significant cost burden in the United States that is

Surgical Site Infections (SSIs) are a significant issue that persists throughout operating suites worldwide. Despite global medical advancements, SSIs still cause substantial morbidity along with a significant cost burden in the United States that is

Hospital linen has been a reported source for pulmonary and cutaneous outbreaks of Murcormycosis.1,2 Although this is a rare occurrence, these infections impact the most vulnerable patients due to their immunocompromised state. Other outbreaks of

Antimicrobial stewardship programs (ASP) have been associated with lower in-hospital antimicrobial consumption, earlier discharge when the oral switch protocol is implemented, and lower hospital costs. Nevertheless, their impact on antimicrobial